Ingredients of Opitron Plus Titan Capsule

Gokshura	Substances that improve sexual desires Substances that provide nourishment to the body. Agents that help in penile erection. A drug which stimulates the production of semen or spermatozoa. It is beneficial for the treatment of sexual disorders such as impotence, erectile dysfunction, and sexual weakness.
Punarnava	Substances that scavange the singlet oxygen molecules in the body.
Ginkgo biloba	Substances that invigorate sex drive. Drugs that are used for their actions on the nervous system and are used to calm down excited nerves
Vitamin B3	Drugs that provide the body with all essential nutrients for proper physical and mental growth.
Ginseng	Agents which help in reducing free radical activity and preventing oxidative stress and damage Substances that lead to heightened sexual desires Drugs that provide the body with all essential nutrients for proper physical and mental growth. Substances that are used to stimulate erection.
Saw palmetto	Agents that improve the erection of penis. Drugs that are used to improve sperm production and treat male sexual disorders.
Capsicum (Bell Pepper)	Drugs which aid in swelling reduction following an injury Substances that can stimulate or reduce the action of immune system molecules in the body.
Horny Goat Weed	Agents that are effective in increasing libido. Substances that are used to stimulate erection.

Opitron Plus Titan Capsule Benefits

Opitron Plus Titan Capsule is used to treat the following -

Main Benefits

Opitron Plus Titan Capsule Dosage

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Age Group	Dosage
Adult	General: Use prescribed amount Before or After Meal: Before meal Single Maximum Dose: 1 Capsule Preferred way of taking: LukeWarm Water Dosage Form: Capsule Dosage Route: Oral Frequency: BID (twice daily)

Opitron Plus Titan Capsule Side Effects

No side effects of Opitron Plus Titan Capsule have been reported in the medical literature. However, you should always consult your doctor before using Opitron Plus Titan Capsule.

Opitron Plus Titan Capsule Related Warnings

Is the use of Opitron Plus Titan Capsule safe for pregnant women?

No research has been done regarding the safety of Opitron Plus Titan Capsule for pregnant women. Therefore, it cannot be said if Opitron Plus Titan Capsule is safe during pregnancy.

Unknown
Is the use of Opitron Plus Titan Capsule safe during breastfeeding?

Side effects of Opitron Plus Titan Capsule for breastfeeding women are not known. This is because research work on this has not been done.

Unknown
What is the effect of Opitron Plus Titan Capsule on the stomach?

Opitron Plus Titan Capsule is considered safe for the stomach.

Safe
Is the use of Opitron Plus Titan Capsule safe for children?

There is no research available on the side effects of Opitron Plus Titan Capsule on children. Therefore, its impact is unknown.

Unknown
Can I take Opitron Plus Titan Capsule with alcohol?

It is difficult to say anything about the effect of Opitron Plus Titan Capsule and alcohol. No research has been done on this.

Unknown
Does Opitron Plus Titan Capsule cause drowsiness?

You can operate a vehicle or heavy machinery after taking Opitron Plus Titan Capsule since it does not cause drowsiness.

No
Is this Opitron Plus Titan Capsule habit forming or addictive?

There is no evidence on the habit-forming effects of Opitron Plus Titan Capsule

No

This medicine data has been created by -

Dr. Braj Bhushan Ojha

BAMS, Gastroenterology, Dermatology, Psychiatry, Ayurveda, Sexology, Diabetology
10 Years of Experience

References

Ministry of Health and Family Welfare. Department of Ayush: Government of India. Volume- I. Ghaziabad, India: Pharmacopoeia Commission for Indian Medicine & Homoeopathy; 1999: Page No 49-52

C.K. Kokate ,A.P. Purohit, S.B. Gokhale. [link]. Forty Seventh Edition. Pune, India: Nirali Prakashan; 2012: Page No 8.76-8.77